Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1949]
News [3653]
Articles [96]
Editorials [5]
Conferences [157]
elearning [19]
WCLC 2025: Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial
WCLC 2025: Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell...
WCLC 2025: No OS benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable stage 3 NSCLC
WCLC 2025: No OS benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable stage...
WCLC 2025: First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed SCLC
WCLC 2025: First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in...
WCLC 2025: NADIM-ADJUVANT trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC
WCLC 2025: NADIM-ADJUVANT trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC
WCLC 2025: Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy
WCLC 2025: Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following...
WCLC 2025: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC
WCLC 2025: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC
WCLC 2025: New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients
WCLC 2025: New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients
Review explores critical role of microbiome in cancer development and treatment
Review explores critical role of microbiome in cancer development and treatment
Plant-based nutrient improves immune cells’ ability to fight cancer
Plant-based nutrient improves immune cells’ ability to fight cancer
New multi-omics study uncovers key RNA-driven network behind colorectal cancer progression and immune resistance
New multi-omics study uncovers key RNA-driven network behind colorectal cancer progression and immune resistance

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation